MILWAUKEE -- The Brewers on Wednesday removed star left fielder Ryan Braun's name from the list of participants for the club's weekend fanfest, citing indirectly his ongoing appeal of a potential suspension under Major League Baseball's Joint Drug Prevention and Treatment Program.
Brewers principal owner Mark Attanasio announced the news in a statement.
"In working through the logistics of this weekend's Brewers On Deck event in Milwaukee with Ryan Braun -- and knowing how much he enjoys interacting candidly with Brewers fans -- we came to the conclusion that this is too sensitive of a time in the confidential process for him to attend this year," Attanasio said. "I speak for everyone at the Brewers, including Ryan, in thanking our fans for their understanding and patience."
Braun had been previously announced as a participant at "On Deck," which features autograph and photo opportunities among other programs. As recently as Monday, when the Brewers hung a banner at Miller Park marking last year's first-place finish in the National League Central, the club's chief spokesperson said Braun was expected to attend.
The reigning National League Most Valuable Player, Braun faces a suspension after reportedly submitting a test during the playoffs that registered a high level of testosterone. His appeal began Jan. 19 in New York, two days before Braun accepted his NL MVP Award in a Baseball Writers' Association of America banquet.
The three-member appeals panel has 25 days to render a decision. It's unclear how much of that time they will take, because an MLB spokesperson declined comment, citing the confidentiality of the process.
"I've chosen to view every challenge I've ever faced as an opportunity, and this will be no different," Braun said in his speech to the BBWAA. "I've always believed that a person's character is revealed through the way they deal with those moments of adversity."
Adam McCalvy is a reporter for MLB.com. Read his blog, Brew Beat, and follow him on Twitter at @AdamMcCalvy. This story was not subject to the approval of Major League Baseball or its clubs.